Wydase

Active Ingredient(s): Hyaluronidase
FDA Approved: * March 22, 1950
Pharm Company: * BAXTER HLTHCARE
Category: Medical Device

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Wydase Overview

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products.[1] The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.[2] In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known a...

Read more Wydase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hyaluronidase

Recent Wydase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hyaluronidase
  • Injection: 1,500 units/vial, 150 units/ml, 150 units/vial, 150unit/ml, 150USPunits/ml, 200 units/vial, 200units/ml, 6,200 units/vial
  • Powder for Reconstitution: 6200IU/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Hyaluronidase or a similar ingredient: (12 results)